We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Diabetes Epidemic Costs Lives and Billions of Dollars

By HospiMedica International staff writers
Posted on 08 Dec 2008
A new study reports that concomitant to diabetes rapidly becoming one of the world's most common diseases, its financial toll is also mounting--to over US$218 billion a year in the United States alone.

Researchers at the Lewin Group (Falls Church, VA, USA) based their calculations on figures derived from databases detailing treatment costs of people with commercial insurance, Medicare and Medicaid, U.S. More...
federal public health surveys, and other sources. The sums include direct medical care costs--from insulin and medication to surgical amputations and hospitalizations--and indirect costs such as lost productivity, disability, and early retirement. A breakdown of the figures estimate the costs to society for people known to have Type 1 or Type 2 diabetes at $174.4 billion combined, diabetics as yet undiagnosed ($18 billion), women who develop gestational diabetes temporarily during pregnancy ($636 million) and sufferers from an increasingly common condition called prediabetes ($25 billion).

Among people known to have diabetes, the new study estimated $10.5 billion in medical costs and $4.4 billion in indirect costs, or a total of $14.9 billion, for people with Type 1 diabetes (or 6% of the 17.5 million Americans diagnosed with diabetes). The study estimated a further $105.7 billion in medical costs and $53.8 billion in indirect costs, totaling $159.5 billion, for people with Type 2 diabetes. The study was financed by Novo Nordisk (Bagsværd, Denmark) in association with the American Diabetes Association (Alexandria, VA, USA).

"Diabetes has not seen a decline or even a plateauing, and the death rate from diabetes continues to rise," said Dana Haza, senior director of the U.S. National Changing Diabetes Program, which includes medical partners such as the American Academy of Family Physicians and American Diabetes Association. "The numbers just keep going higher and higher, and what we want to say is, It's time for government and businesses to focus on it."

"This study gives a very persuasive argument to employers to invest in a culture of health in their workforce," said Andrew Webber, president and CEO of the U.S. National Business Coalition on Health (Washington, DC, USA), a group that includes 61 business coalitions with about 7,000 employers and 35 million employees and dependents.

Related Links:
Lewin Group
Novo Nordisk
American Diabetes Association
U.S. National Business Coalition on Health

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.